Researchers conducted a case-control study assessing the brain circuit commonalities in the functional connections of lesions that cause secondary psychosis.
Dozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that ...